PHLPP2 and urinary bladder carcinoma: Interestingly, MEG3 interacts with miR-494 to repress bladder cancer progression through targeting PTEN,49 and MEG3 binds with miR-27a to promote PHLPP2 protein translation and impairs bladder cancer invasion.50